Last reviewed · How we verify
sublingual sedation
At a glance
| Generic name | sublingual sedation |
|---|---|
| Sponsor | Nantes University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Use of Sublingual Melatonin Premedication in Geriatric Cataract Surgery (PHASE4)
- A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR) (PHASE3)
- Comparison of Respiratory Tolerance to I.V. Versus Sublingual Sedation During Bronchoscopy. (TORSIV) (PHASE4)
- Safety and Potential Effect of Innovative Cell-based Therapy Using Adipose-derived Stromal Vascular Fraction in Patients With Autoimmune Xerostomia (PHASE1, PHASE2)
- A Study of MELT-300 (Midazolam and Ketamine Sublingual Tablets) for Sedation and Intraoperative Ocular Analgesia in Participants Undergoing Cataract Extraction With Lens Replacement (CELR) (PHASE2)
- The Use of Sedation Drugs in the Procedure of Administering Surfactant Without Intubation (LISA/MIST) (PHASE1)
- Sublingual Versus Intranasal Administration of Dexmedetomidine for Sedation of Children Undergoing Dental Treatment (PHASE2, PHASE3)
- Analgesic Efficacy of US-Guided Interscalene Block Versus Supraclavicular Block for Ambulatory Arthroscopic Rotator Cuff Repair (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- sublingual sedation CI brief — competitive landscape report
- sublingual sedation updates RSS · CI watch RSS
- Nantes University Hospital portfolio CI